<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://pedpalascnetlibrary.omeka.net/items/browse?tags=Richter+JF&amp;sort_field=added&amp;sort_dir=a&amp;output=omeka-xml" accessDate="2026-05-09T15:09:23-04:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>40</perPage>
      <totalResults>1</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="14308" public="1" featured="1">
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="53">
          <name>Citation List Month</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="101464">
              <text>Backlog</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="56">
          <name>URL Address</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="101472">
              <text>&lt;a href="http://doi.org/10.1038/sj.npp.1301393" target="_blank" rel="noreferrer"&gt;http://doi.org/10.1038/sj.npp.1301393&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="101465">
                <text>Inhibition of inflammatory pain by CRF at peripheral, spinal and supraspinal sites: involvement of areas coexpressing CRF receptors and opioid peptides</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="101466">
                <text>Neuropsychopharmacology</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="101467">
                <text>2007</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="101468">
                <text>Male; Pain Measurement; Animals; Rats; Biomarkers of Pain; Dose-Response Relationship; Drug; Receptors; Freund's Adjuvant; Wistar; Animal; Disease Models; Analgesics/administration &amp; dosage; Drug Administration Routes; Pain Threshold/drug effects; Brain/drug effects/metabolism; Spinal Cord/drug effects/metabolism; Corticotropin-Releasing Hormone/administration &amp; dosage; Opioid Peptides/metabolism; Corticotropin-Releasing Hormone/metabolism; Ganglia; Hormone Antagonists/administration &amp; dosage; Inflammation/chemically induced/complications; Pain/drug therapy/etiology/pathology; Sciatic Nerve/pathology; Spinal/drug effects/metabolism</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="101469">
                <text>Mousa SA; Bopaiah CP; Richter JF; Yamdeu RS; Schafer M</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="101470">
                <text>There is conflicting evidence on the antinociceptive effects of corticotropin-releasing factor (CRF) along the neuraxis of pain transmission and the responsible anatomical sites of CRF's action at the level of the brain, spinal cord and periphery. In an animal model of tonic pain, that is, Freunds complete adjuvant (FCA) hindpaw inflammation, we systematically investigated CRF's ability to modulate inflammatory pain at those three levels of pain transmission by algesiometry following the intracerebroventricular, intrathecal, and intraplantar application of low, systemically inactive doses of CRF. At each level, CRF elicits potent antinociceptive effects, which are dose dependent and antagonized by local, but not systemic CRF receptor antagonist alpha-helical CRF indicating CRF receptor specificity. Consistently, we have identified by immunohistochemistry multiple brain areas, inhibitory interneurons within the dorsal horn of the spinal cord as well as immune cells within subcutaneous tissue--but not peripheral sensory neurons--that coexpress both CRF receptors and opioid peptides. In line with these anatomical findings, local administration of CRF together with the opioid receptor antagonist naloxone dose-dependently reversed CRF's antinociceptive effects at each of these three levels of pain transmission. Therefore, local application of low, systemically inactive doses of CRF at the level of the brain, spinal cord and periphery inhibits tonic inflammatory pain most likely through an activation of CRF receptors on cells that coexpress opioid peptides which results in opioid-mediated pain inhibition. Future studies have to delineate whether endogenous CRF at these three levels contributes to the body's response to cope with the stressful stimulus pain in an opioid-mediated manner.</text>
              </elementText>
              <elementText elementTextId="101478">
                <text>2007</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="101471">
                <text>&lt;a href="http://doi.org/10.1038/sj.npp.1301393" target="_blank" rel="noreferrer"&gt;10.1038/sj.npp.1301393&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="101473">
                <text>Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="51">
            <name>Type</name>
            <description>The nature or genre of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="101474">
                <text>Journal Article</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="5090">
        <name>2007</name>
      </tag>
      <tag tagId="8635">
        <name>Analgesics/administration &amp; dosage</name>
      </tag>
      <tag tagId="9040">
        <name>Animal</name>
      </tag>
      <tag tagId="6797">
        <name>Animals</name>
      </tag>
      <tag tagId="7679">
        <name>Backlog</name>
      </tag>
      <tag tagId="7835">
        <name>Biomarkers of Pain</name>
      </tag>
      <tag tagId="23332">
        <name>Bopaiah CP</name>
      </tag>
      <tag tagId="20117">
        <name>Brain/drug effects/metabolism</name>
      </tag>
      <tag tagId="16627">
        <name>Corticotropin-Releasing Hormone/administration &amp; dosage</name>
      </tag>
      <tag tagId="23325">
        <name>Corticotropin-Releasing Hormone/metabolism</name>
      </tag>
      <tag tagId="15232">
        <name>Disease Models</name>
      </tag>
      <tag tagId="8848">
        <name>Dose-Response Relationship</name>
      </tag>
      <tag tagId="8849">
        <name>Drug</name>
      </tag>
      <tag tagId="12185">
        <name>Drug Administration Routes</name>
      </tag>
      <tag tagId="10264">
        <name>Freund's Adjuvant</name>
      </tag>
      <tag tagId="23326">
        <name>Ganglia</name>
      </tag>
      <tag tagId="23327">
        <name>Hormone Antagonists/administration &amp; dosage</name>
      </tag>
      <tag tagId="23328">
        <name>Inflammation/chemically induced/complications</name>
      </tag>
      <tag tagId="7682">
        <name>Journal Article</name>
      </tag>
      <tag tagId="612">
        <name>Male</name>
      </tag>
      <tag tagId="11330">
        <name>Mousa SA</name>
      </tag>
      <tag tagId="23324">
        <name>Neuropsychopharmacology</name>
      </tag>
      <tag tagId="16446">
        <name>Opioid Peptides/metabolism</name>
      </tag>
      <tag tagId="1300">
        <name>Pain Measurement</name>
      </tag>
      <tag tagId="15718">
        <name>Pain Threshold/drug effects</name>
      </tag>
      <tag tagId="23329">
        <name>Pain/drug therapy/etiology/pathology</name>
      </tag>
      <tag tagId="10263">
        <name>Rats</name>
      </tag>
      <tag tagId="9504">
        <name>Receptors</name>
      </tag>
      <tag tagId="23333">
        <name>Richter JF</name>
      </tag>
      <tag tagId="10279">
        <name>Schafer M</name>
      </tag>
      <tag tagId="23330">
        <name>Sciatic Nerve/pathology</name>
      </tag>
      <tag tagId="20120">
        <name>Spinal Cord/drug effects/metabolism</name>
      </tag>
      <tag tagId="23331">
        <name>Spinal/drug effects/metabolism</name>
      </tag>
      <tag tagId="10268">
        <name>Wistar</name>
      </tag>
      <tag tagId="23334">
        <name>Yamdeu RS</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
